| Bioactivity | SMRT peptide is one of the co-repressors of BCL6 BTB domain interaction. SMRT peptide binds to the BTB domain of BCL6 and enhances the transcriptional repression function of BCL6. SMRT peptide can be used to study protein-protein interactions[1]. |
| CAS | 857026-08-5 |
| Sequence | Leu-Val-Ala-Thr-Val-Lys-Glu-Ala-Gly-Arg-Ser-Ile-His-Glu-Ile-Pro-Arg |
| Shortening | LVATVKEAGRSIHEIPR |
| Formula | C82H142N26O24 |
| Molar Mass | 1876.16 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Ai Y, et al. Progress toward B-cell lymphoma 6 BTB domain inhibitors for the treatment of diffuse large B-cell lymphoma and beyond[J]. Journal of medicinal chemistry, 2021, 64(8): 4333-4358. |
SMRT peptide
CAS: 857026-08-5 F: C82H142N26O24 W: 1876.16
SMRT peptide is one of the co-repressors of BCL6 BTB domain interaction. SMRT peptide binds to the BTB domain ofBCL6 and
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.